SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-23-004070
Filing Date
2023-01-19
Accepted
2023-01-19 17:54:15
Documents
1
Period of Report
2023-01-12

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 4077
  Complete submission text file 0001209191-23-004070.txt   5732
Mailing Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503
Business Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503 310-214-0065
Emmaus Life Sciences, Inc. (Issuer) CIK: 0000822370 (see all company filings)

IRS No.: 870419387 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 20725 S. WESTERN AVE. SUITE 136 TORRANCE CA 90501
Business Address
LEE WILLIS C (Reporting) CIK: 0001517775 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-35527 | Film No.: 23538405